4-Nitrobenzoate sodium | 3847-57-2

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 4-Nitrobenzoate sodium
• CAS: 3847-57-2
• 化学式: C7H5NNaO4
• 分子量: 190.11
• InChiKey: MQLVXZMQWBRZIL-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.91
• 重原子数：
  13
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  83.1
• 氢给体数：
  1
• 氢受体数：
  4

安全信息

• 危险性防范说明：
  P280,P305+P351+P338
• 危险性描述：
  H317,H319

文献信息

• Process for producing allyl halide compound
  申请人：——

  公开号：US20020107422A1

  公开（公告）日：2002-08-08

  There are disclosed a composition comprising (E)-1,4-dibromo-2-methyl-2-butene and (Z)-1,4-dibromo-2-methyl-2-butene, wherein the ratio of the E isomer to the total amount of the E and Z isomers is 0.9 or more; a process for producing the same and a process using the same to produce an allyl halide compound of formula (1): 1 wherein X denotes a bromine atom, Y denotes an ArS(O) 2 group or an RCOO group, wherein Ar denotes an aryl group which may be substituted and R denotes a hydrogen atom, a lower alkyl group or an aryl group which may be substituted, and the wavy line means that the derivative is a mixture of an E or Z geometrical isomer.

  本发明涉及一种包含(E)-1,4-二溴-2-甲基-2-丁烯和(Z)-1,4-二溴-2-甲基-2-丁烯的组合物，其中E异构体与E和Z异构体的总量之比为0.9或更高；一种生产该组合物的方法以及使用该组合物生产化合物的方法，所述化合物的分子式为（1）：其中X代表溴原子，Y代表ArS(O)2基团或RCOO基团，其中Ar代表可能被取代的芳基，R代表氢原子、低碳烷基或可能被取代的芳基，波浪线表示衍生物是E或Z几何异构体的混合物。
• Agent for capturing substance having anionic substituent
  申请人：Koike Tohru

  公开号：US20060131239A1

  公开（公告）日：2006-06-22

  A polymer carrier to which a prescribed zinc complex group is binding directly or through a spacer, having property to bond, under a certain condition, to an anionic substituent (a phosphate group, for example), showing low solubility to a solvent (preferably insolubility to a solvent) as a whole, and being capable of capturing, separating and purifying easily a substance having an anionic substituent (a phosphate group, for example).

  一种聚合物载体，其中一个预定的锌配合物基团直接或通过间隔物结合，具有在特定条件下与阴离子取代基（例如磷酸基团）结合的性质，整体上对溶剂具有低溶解度（最好是不溶于溶剂），并且能够轻松捕获、分离和纯化具有阴离子取代基（例如磷酸基团）的物质。
• PROCESSES FOR PREPARING ANTIVIRAL COMPOUNDS
  申请人：Gilead Pharmasset LLC

  公开号：US20150361073A1

  公开（公告）日：2015-12-17

  The present disclosure provides processes for the preparation of a compound of formula: which is useful as an antiviral agent. The disclosure also provides compounds that are synthetic intermediates.

  本公开提供了制备一种化合物的方法，该化合物的化学式如下所示：该化合物可用作抗病毒药物。本公开还提供了合成中间体化合物。
• METHOD FOR PRODUCING A RUTHENIUM COMPLEX
  申请人：Nara Hideki

  公开号：US20100076210A1

  公开（公告）日：2010-03-25

  Provided is a method for producing a ruthenium complex comprises the step of reacting a ruthenium compound represented by general formula (1): [RuX(L)(PP)]X   (1), wherein Ru represents a ruthenium atom; X represents a halogen atom; L represents an arene; and PP represents an optically active bisphosphine, with a carboxylate salt represented by general formula (2): R 1 CO 2 M   (2), wherein M represents a monovalent cation; and R 1 represents a group selected from the group consisting of alkyl groups, haloalkyl groups, phenyl groups optionally having a substituent(s), 1-aminoalkyl groups and 1-amino-1-phenylalkyl groups, to produce a ruthenium complex represented by general formula (3): Ru(OCOR 1 ) 2 (PP)   (3), wherein R 1 represents the group selected from the group consisting of alkyl groups, haloalkyl groups, phenyl groups optionally having a substituent(s), 1-aminoalkyl groups and 1-amino-1-phenylalkyl groups; and PP represents the optically active bisphosphine.

  提供的是一种制备钌配合物的方法，包括以下步骤：将由通式（1）表示的钌化合物与由通式（2）表示的羧酸盐反应，其中通式（1）为：[RuX(L)(PP)]X，其中Ru代表钌原子；X代表卤素原子；L代表芳烃；PP代表光学活性双膦；通式（2）为：R1CO2M，其中M代表一价阳离子；R1代表从烷基、卤代烷基、苯基（可选地带有取代基）、1-氨基烷基和1-氨基-1-苯基烷基组成的群中选择的基团，以制备由通式（3）表示的钌配合物：Ru(OCOR1)2(PP)，其中R1代表从烷基、卤代烷基、苯基（可选地带有取代基）、1-氨基烷基和1-氨基-1-苯基烷基组成的群中选择的基团；PP代表光学活性双膦。
• [EN] PROCESSES FOR PREPARING ANTIVIRAL COMPOUNDS<br/>[FR] PROCÉDÉS DE PRÉPARATION DE COMPOSÉS ANTIVIRAUX
  申请人：GILEAD PHARMASSET LLC

  公开号：WO2015191437A1

  公开（公告）日：2015-12-17

  The present disclosure provides processes for the preparation of a compound of formula: which is useful as an antiviral agent. The disclosure also provides compounds that are synthetic intermediates.

  本披露提供了一种制备式为的化合物的过程：它可用作抗病毒剂。该披露还提供了合成中间体化合物。